TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.

Richard D Carvajal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.